News

At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at www.janssen.com/newzealand. Follow us at @Janssenanz.

> Media Contact
Email: [email protected]
This contact is only for journalists. If you are not a member of the media then please submit your query via www.janssen.com/newzealand/contact-us.

> News Press Releases

8 August, 2023
Read the report: The future of Aotearoa’s Medicines access - fixing the funding model
https://www.janssen.com/newzealand/sites/www_janssen_com_newzealand/files/shawviewnzmedicinesaccessreport_aug_2023.pdf.

1 June, 2022
Janssen responds to Pharmac Independent Review panel final report with three-step-plan to improve medicine’s access
https://www.janssen.com/newzealand/sites/www_janssen_com_newzealand/files/media_release_-_janssen_johnson_johnson_responds_to_pharmac_review.pdf.

Read More about our response to COVID https://www.janssen.com/newzealand/our-response-covid-19.

Single-shot COVID-19 Vaccine Janssen Granted Provisional Approval by Medsafe in New Zealand
https://www_janssen_com_newzealand/sites/single-shot_covid-19_vaccine_janssen_granted_provisional_approval_by_medsafe.pdf